Type | Public | |
Founded | 1876 | |
HQ | Indianapolis, IN, US | Map |
Website | lilly.com | |
Employee Ratings | ||
Overall Culture | A- | More |
USD | |
---|---|
Revenue (Q1, 2022) | 7.8b |
Gross profit (Q1, 2022) | 5.7b |
Net income (Q1, 2022) | 1.9b |
Market capitalization (24-Jun-2022) | 309.4b |
Closing stock price (24-Jun-2022) | 325.6 |
Cash (30-Sept-2021) | 3.8b |
EV | 322.7b |
USD | Q1, 2010 | Q2, 2010 | Q3, 2010 | Q4, 2010 | Q1, 2011 | Q2, 2011 | Q3, 2011 | Q4, 2011 | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q4, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 123.5k | 5.2b | 5.9b | 6.0b | 6.5b | 6.1b | 6.6b | 5.9b | 4.1b | 4.3b | 5.3b | 4.0b | 3.9b | 3.8b | 4.4b | 3.9b | 3.8b | 3.2b | 3.1b | 3.3b | 3.2b | 2.3b | 3.2b | 3.5b | 2.6b | 3.1b | 3.7b | 3.1b | 6.8b | 9.0b | 2.0b | 2.3b | 1.6b | 1.7b | 2.4b | 3.6b | 3.0b | 3.2b | 3.8b |
Accounts Receivable | 3.2b | 3.1b | 3.3b | 3.5b | 3.7b | 3.8b | 3.5b | 3.6b | 3.4b | 3.2b | 3.3b | 3.3b | 3.4b | 3.6b | 3.4b | 3.0b | 3.2b | 3.1b | 3.1b | 3.3b | 3.4b | 3.6b | 3.9b | 3.8b | 4.0b | 4.3b | 4.4b | 4.5b | 4.8b | 4.9b | 4.2b | 4.6b | 4.4b | 5.1b | 4.8b | 4.9b | 5.6b | 5.8b | 5.9b |
Prepaid Expenses | 1.0b | 1.1b | 1.2b | 608.9m | 1.1b | 867.3m | 799.1m | 654.9m | 998.5m | 953.3m | 790.1m | 822.3m | 987.9m | 988.9m | 853.4m | 1.1b | 1.1b | 821.5m | 797.0m | 730.1m | 762.4m | 792.0m | 789.5m | 756.5m | 821.6m | 1.0b | 1.1b | 1.6b | 1.7b | 1.9b | 2.2b | 2.3b | 2.4b | 2.8b | 3.1b | 3.2b | 3.2b | 3.3b | 3.1b |
Inventories | 2.5b | 2.2b | 2.7b | 2.5b | 2.8b | 2.9b | 2.5b | 2.3b | 2.4b | 2.3b | 2.6b | 2.6b | 2.6b | 2.7b | 3.0b | 3.0b | 3.2b | 2.8b | 3.0b | 3.3b | 3.4b | 3.7b | 3.8b | 3.9b | 4.0b | 4.3b | 4.4b | 4.6b | 4.2b | 4.1b | 3.1b | 3.2b | 3.1b | 3.1b | 3.3b | 3.6b | 3.7b | 3.8b | 3.9b |
USD | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 |
---|---|---|---|---|---|---|---|---|---|
Net Income | 4.2b | 5.6b | 6.8b | 1.5b | 2.9b | 4.1b | 1.4b | 2.7b | 3.9b |
Depreciation and Amortization | 356.5m | 603.9m | 891.9m | 273.6m | 598.0m | 956.4m | 350.3m | 719.6m | 1.1b |
Cash From Operating Activities | 311.3m | 1.4b | 2.9b | 382.4m | 2.9b | 4.7b | 1.7b | 3.5b | 5.1b |
Purchases of PP&E | (203.7m) | (444.0m) | (707.4m) | (258.3m) | (540.1m) | (933.2m) | (300.3m) | (681.6m) | (1.0b) |
USD | Q1, 2010 |
---|---|
Debt/Equity | 0.6 x |
Debt/Assets | 0.2 x |
Financial Leverage | 2.6 x |
Company Name | Date | Deal Size |
---|---|---|
Protomer Technologies | July 14, 2021 | $1 b |
Prevail Therapeutics Inc. | January 01, 2021 | $880 m |
Disarm Therapeutics | October 15, 2020 | $135 m |
Disarm Therapeutics | October 15, 2020 | $135 m |
Dermira | January 10, 2020 | $849.3 m |
Dermira | January 10, 2020 | $1.1 b |
Loxo Oncology | January 07, 2019 | $6.92 b |
AurKa Pharma | May 15, 2018 | $575 m |
ARMO BioSciences Inc | May 11, 2018 | $1.6 b |
CoLucid Pharmaceuticals | January 18, 2017 | $960 m |
Eli Lilly revenue breakdown by business segment: 44.2% from Diabetes, 19.1% from Oncology, 11.8% from Immunology, 5.6% from Neuroscience and 19.3% from Other
Eli Lilly revenue breakdown by geographic segment: 8.4% from Japan, 5.9% from China , 16.9% from Europe, 9.5% from Other foreign countries and 59.4% from United States
Eli Lilly has 135.09k Twitter Followers. The number of followers has increased 0.5% month over month and increased 1.2% quarter over quarter
22.3k
Tweets
1.3k
Following
135.1k
Followers
39
Tweets last 30 days
3.6
Avg. likes per Tweet
61.5%
Tweets with engagement
A-
74/100
A-
76/100
A-
76/100
C+
68/100
When was Eli Lilly founded?
Eli Lilly was founded in 1876.
Who are Eli Lilly key executives?
Eli Lilly's key executives are David A. Ricks, Anat Ashkenazi and Stephen F. Fry.
How many employees does Eli Lilly have?
Eli Lilly has 35,000 employees.
What is Eli Lilly revenue?
Latest Eli Lilly annual revenue is $28.3 b.
What is Eli Lilly revenue per employee?
Latest Eli Lilly revenue per employee is $809.1 k.
Who are Eli Lilly competitors?
Competitors of Eli Lilly include Shionogi, Boehringer Ingelheim and Sanofi.
Where is Eli Lilly headquarters?
Eli Lilly headquarters is located at 893 Delaware St, Indianapolis.
Where are Eli Lilly offices?
Eli Lilly has offices in Indianapolis, Branchburg, Cambridge, New York and in 43 other locations.
How many offices does Eli Lilly have?
Eli Lilly has 49 offices.
Receive alerts for 300+ data fields across thousands of companies